Literature DB >> 16369617

Recommendations for monitoring serum vancomycin concentrations.

C W James1, C Gurk-Turner.   

Abstract

Entities:  

Year:  2001        PMID： 16369617      PMCID： PMC1291340          DOI： 10.1080/08998280.2001.11927763

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  14 in total

1.  Therapeutic monitoring of vancomycin.

Authors:  D E Palmer-Toy
Journal:  Arch Pathol Lab Med       Date:  2000-02       Impact factor: 5.534

2.  Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.

Authors:  C M Karam; P S McKinnon; M M Neuhauser; M J Rybak
Journal:  Pharmacotherapy       Date:  1999-03       Impact factor: 4.705

3.  Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report.

Authors:  J E GERACI; F R HEILMAN; D R NICHOLS; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1958-04-02

Review 4.  Vancomycin toxicity. What is the evidence for dose dependency?

Authors:  S B Duffull; E J Begg
Journal:  Adverse Drug React Toxicol Rev       Date:  1994

Review 5.  Monitoring serum vancomycin levels: climbing the mountain because it is there?

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

Review 6.  Serum vancomycin concentrations: reappraisal of their clinical value.

Authors:  T G Cantú; N A Yamanaka-Yuen; P S Lietman
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

Review 7.  The therapeutic monitoring of antimicrobial agents.

Authors:  E J Begg; M L Barclay; C J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 8.  Vancomycin therapeutic drug monitoring: is it necessary?

Authors:  C D Freeman; R Quintiliani; C H Nightingale
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

Review 9.  Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides.

Authors:  A P MacGowan
Journal:  Ther Drug Monit       Date:  1998-10       Impact factor: 3.681

10.  Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.

Authors:  A E Zimmermann; B G Katona; K I Plaisance
Journal:  Pharmacotherapy       Date:  1995 Jan-Feb       Impact factor: 4.705
View more
  4 in total

1.  Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?

Authors:  Ömür Çağlar; Mehmet Kaymakoğlu; Akın Çil; Bülent Atilla; Fatma Sarıcaoğlu; Mazhar Tokgözoğlu
Journal:  Acta Orthop Traumatol Turc       Date:  2021-01       Impact factor: 1.511

2.  Antibiotic Elution Characteristics and Pharmacokinetics of Gentamicin and Vancomycin from a Mineral Antibiotic Carrier: An in vivo Evaluation of 32 Clinical Cases.

Authors:  Thomas Colding-Rasmussen; Peter Horstmann; Michael Mørk Petersen; Werner Hettwer
Journal:  J Bone Jt Infect       Date:  2018-10-20

3.  Long-term vancomycin use had low risk of ototoxicity.

Authors:  Clayton Humphrey; Michael P Veve; Brian Walker; Mahmoud A Shorman
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

4.  Periprosthetic Joint Infection (PJI)-Results of One-Stage Revision with Antibiotic-Impregnated Cancellous Allograft Bone-A Retrospective Cohort Study.

Authors:  Gregor Dersch; Heinz Winkler
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.